Browsing Tag
Melbourne
49 posts
Synertec (ASX: SOP) drops as Hitachi Energy collaboration excitement fades into post-update profit-taking
Synertec just signed Hitachi Energy. The Powerhouse is AI-powered grid tech. The market cap is A$12m. The analyst consensus target is 400% above current.
Tabcorp (ASX: TAH) collapse deepens as AUSTRAC compliance probe revives 2017 AML breach memories
Tabcorp paid A$45m for AML breaches in 2017. AUSTRAC just sent another letter. The market priced in the worst case before management could speak.
REA Group (ASX: REA) shares jump as Q3 FY2026 result lifts cost guidance and confirms residential recovery
REA Group fell 9.6% on H1 results in February. Today's Q3 print rewrites that thesis. Listing volumes are back, yield is at 14%, costs are being held.
Textron Inc. (NYSE: TXT) strengthens Asia-Pacific support with Essendon Fields expansion
APAC aircraft demand is rising faster than service capacity. Textron Aviation’s Melbourne bet could reshape regional support economics.
Pinnacle Investment Management (ASX: PNI) share price jumps 5% after Pacific Asset Management completion
Pinnacle just closed the $419m PAM deal and the stock bounced 5%. Affiliate FUM hits $202.5bn. Performance fees are the next test in July.
Persistent Systems (NSE: PERSISTENT) grows at five times Infosys’s guided pace in FY26 as AI deal wins accelerate
Persistent Systems posts $1.65B FY26 revenue with 17.4% growth and 15.6% EBIT margin. Read what the 24th consecutive growth quarter signals for Indian IT. →
Atomos (ASX: AMS) bets on new product cycle and NAB Show 2026 to lock in its turnaround
Atomos (ASX: AMS) returned to profit in H1 FY2026 with 28% revenue growth. Here is the retail investor roadmap for the next phase of its turnaround.
Algorae Pharmaceuticals (ASX: 1AI) raises A$4m to fund dual commercial and AI drug discovery growth strategy
Algorae Pharmaceuticals (ASX: 1AI) raises A$3.99m to scale AlgoraeRx commercial portfolio and advance AlgoraeOS AI drug pipeline. Read the full strategic analysis.
Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform
Catapult Sports (ASX: CAT) records 27-28% ACV growth and 50% EBITDA jump in FY26. Read what the dual acquisitions mean for the sports analytics race. Read more.
Careteq (ASX: CTQ) raises A$2.2m at steep discount to fund acquisitions and clear debt as stock trades near 52-week low
Careteq (ASX: CTQ) raises A$2.2M via a two-tranche placement at A$0.005 per share to fund acquisitions, repay debt, and support working capital. Read the full analysis.